Total Payments
$36,106
2024 Payments
$6,516
Companies
35
Transactions
122
Medicare Patients
2,152
Medicare Billing
$285,480
Payment Breakdown by Category
Consulting$23,468 (65.0%)
Other$7,020 (19.4%)
Travel$3,005 (8.3%)
Food & Beverage$2,478 (6.9%)
Education$135.29 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $23,468 | 15 | 65.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,020 | 2 | 19.4% |
| Travel and Lodging | $3,005 | 16 | 8.3% |
| Food and Beverage | $2,478 | 81 | 6.9% |
| Education | $135.29 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $8,817 | 8 | $0 (2024) |
| Incyte Corporation | $8,727 | 14 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $5,217 | 8 | $0 (2024) |
| Amgen Inc. | $4,572 | 9 | $0 (2019) |
| Exelixis Inc. | $2,051 | 6 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,763 | 6 | $0 (2019) |
| BeiGene USA, Inc. | $1,667 | 2 | $0 (2024) |
| BeiGene, Ltd. | $525.00 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $517.62 | 2 | $0 (2021) |
| EMD Serono, Inc. | $517.54 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,516 | 21 | JAZZ PHARMACEUTICALS INC. ($6,057) |
| 2023 | $7,644 | 15 | AstraZeneca Pharmaceuticals LP ($2,787) |
| 2022 | $4,936 | 15 | Incyte Corporation ($4,634) |
| 2021 | $4,455 | 14 | Incyte Corporation ($2,793) |
| 2020 | $1,400 | 7 | Incyte Corporation ($1,300) |
| 2019 | $8,370 | 20 | Amgen Inc. ($4,544) |
| 2018 | $2,728 | 26 | AstraZeneca Pharmaceuticals LP ($2,408) |
| 2017 | $56.32 | 4 | EMD Serono, Inc. ($17.54) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| Category: Hematology | ||||||
| 12/02/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.97 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $15.52 | General |
| 10/31/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $128.63 | General |
| Category: Vascular | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $39.73 | General |
| 09/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.52 | General |
| 08/16/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | In-kind items and services | $100.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/05/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | In-kind items and services | $45.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/05/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/28/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,060.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/18/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $117.01 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/17/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | In-kind items and services | $557.20 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/17/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Travel and Lodging | In-kind items and services | $160.17 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/29/2023 | Jazz Pharmaceuticals Inc. | ZANIDATAMAB | Consulting Fee | Cash or cash equivalent | $2,760.00 | General |
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,497.50 | General |
| Category: Oncology | ||||||
| 10/16/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $94.12 | General |
| Category: Heart Failure | ||||||
| 10/16/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 580 | 1,035 | $225,269 | $77,293 |
| 2022 | 7 | 619 | 1,119 | $246,446 | $84,655 |
| 2021 | 8 | 492 | 923 | $204,403 | $70,936 |
| 2020 | 7 | 461 | 853 | $186,635 | $52,596 |
Total Patients
2,152
Total Services
3,930
Medicare Billing
$285,480
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 246 | 599 | $119,800 | $42,342 | 35.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 81 | 138 | $37,950 | $13,914 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 114 | 144 | $20,880 | $6,705 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 43 | 43 | $17,200 | $5,656 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 39 | 39 | $15,249 | $3,801 | 24.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $6,400 | $1,937 | 30.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $4,420 | $1,642 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 20 | $2,800 | $1,118 | 39.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Facility | 2023 | 15 | 19 | $570.00 | $176.51 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 272 | 674 | $134,800 | $46,548 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 95 | 151 | $41,525 | $15,975 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 67 | 67 | $26,800 | $8,715 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 133 | 171 | $24,795 | $7,875 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $10,166 | $2,409 | 23.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $6,400 | $2,382 | 37.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 14 | $1,960 | $750.70 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 155 | 485 | $97,000 | $34,067 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 62 | 100 | $27,500 | $10,741 | 39.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 62 | 62 | $24,800 | $8,699 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 116 | 166 | $24,070 | $7,834 | 32.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 38 | 38 | $14,858 | $3,749 | 25.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 19 | $7,600 | $2,721 | 35.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 32 | $4,480 | $1,685 | 37.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 20 | 21 | $4,095 | $1,440 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 148 | 435 | $87,000 | $23,935 | 27.5% |
About Dr. Robin Jacob, MD
Dr. Robin Jacob, MD is a Hematology & Oncology healthcare provider based in Cookeville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1962652487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Jacob, MD has received a total of $36,106 in payments from pharmaceutical and medical device companies, with $6,516 received in 2024. These payments were reported across 122 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($23,468).
As a Medicare-enrolled provider, Jacob has provided services to 2,152 Medicare beneficiaries, totaling 3,930 services with total Medicare billing of $285,480. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Cookeville, TN
- Active Since 09/19/2008
- Last Updated 05/27/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1962652487
Products in Payments
- ZEPZELCA (Drug) $6,057
- MONJUVI (Drug) $3,934
- ZANIDATAMAB $2,760
- IMFINZI (Biological) $2,498
- FASLODEX (Drug) $2,386
- BRUKINSA (Drug) $2,192
- Cabometyx (Drug) $2,051
- Vitrakvi (Drug) $1,726
- Tepmetko (Drug) $500.00
- XOSPATA (Drug) $500.00
- HD-IVUS (Device) $276.05
- OPTIS (Device) $128.63
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $125.09
- AMPLATZER (Device) $99.78
- OPDIVO (Biological) $70.64
- KEYTRUDA (Biological) $64.13
- RXi Systems (Device) $56.05
- KRAZATI (Drug) $42.00
- FOTIVDA (Drug) $39.88
- ERLEADA (Drug) $34.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.